| Tag | Content |
|---|
EnhancerAtlas ID | HS120-03348 |
Organism | Homo sapiens |
Tissue/cell | LNCaP-abl |
Coordinate | chr19:36193030-36193820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_59463 | chr19:36184851-36210443 | Ly3 | | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | CTGGGATTAC AGGCGTGAGC CACCACGTCC GGCCCCTTCC CCCATTTTAG CGGTTTCGCT 60
CCCTATCGGG GCCAGGGACG CCTCAGGCTG TCTCGGTCAG GACCTACAGC TCCGGTTGTT 120
GTCCCAGGCT CTTCCGCGAG GTGCTCTCCT GTCTCCTGAC CACCCCCATT CCTCCCCACT 180
CCAGCTCCTC AGCGAGCGGC TGCGAAGGAC GCGCACAACA ACACTCCGCG CAGCGGGAAG 240
GTACCGAACT CGCATCGCAG CCTGAAACTG CTCAACTAAG CTCCCGCCCC GCTGCTCTCT 300
GGTCAATCTA AAGCGAAGAC GAGCCTTAGG GCCAATCAGA AGCGACAGCG GTGGAGTCAT 360
GCCCGCCTGC TTGAGGCGCC CTGGCGTCTC ATTGGCTATG CTTGAGAACG AATCCCAGGC 420
TAAGCCACTT AGAAAGGAGC GGAGCCAGCC AATCAGCGGT GCAACCGCCG CGGGGGCCGG 480
GCCAGAAGCC CCGCAGACAA GCACCTCGGG AGACTGGCGA GGGGCGAGCT CGCAGCTTGT 540
TAGCCCCGAA GCCCTGCCCA GGGGGAAACC CTGCTGGAGG GAGTCTAACC CCCGGGCCAG 600
TTAATGTTGG GGCAGCGCAA TCGGCCGTTC CCTCTGCGGT ATGGTTGGAG GTGGGAGTGC 660
TGACACGTCC GCGCGCAGTT ACTCCTGGCT GAGCATACAG TCGAGGTGGC AGTGGGAATT 720
GGAAGTGCAA GTGTCACGCT GCCAATCACG GGGCAAGGCA CTGCCCCCCT CTTGTGTCTT 780
TCCTGTCCCT 790
|
